CELLECTAR BIOSCIENCES INC

Inactive Instrument

Transcripts Cellectar Biosciences Inc Nasdaq

Equities

US15117F2039

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Mar. 28	Roth MKM Raises Cellectar Biosciences' Price Target to $28 From $20, Retains Buy Rating	MT
Mar. 28	Oppenheimer Adjusts Cellectar Biosciences Price Target to $12 From $11, Maintains Outperform Rating	MT

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Cellectar Biosciences, Inc., 2023 Earnings Call, Mar 27, 2024	Mar. 27
Transcript : Cellectar Biosciences, Inc. - Special Call	Jan. 19
Transcript : Cellectar Biosciences, Inc. - Special Call	Jan. 08
Transcript : Cellectar Biosciences, Inc., Q3 2023 Earnings Call, Nov 02, 2023	Nov. 02
Transcript : Cellectar Biosciences, Inc. - Special Call	21-06-04
Transcript : Cellectar Biosciences, Inc. Presents at Oppenheimer 31st Annual Healthcare Conference, Mar-16-2021 08:00 AM	21-03-16
Transcript : Cellectar Biosciences, Inc. Presents at BIO CEO & Investor Digital Conference 2021, Feb-16-2021	21-02-15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer